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RESEARCH ARTICLE
Relationship Between the Cortisol-Estradiol Phase 
Difference and Affect in Women
Karyn Geralyn Butler
Affective disorders impact women’s health, with a lifetime prevalence of over twelve per cent. They have 
been correlated with reproductive cycle factors, under the regulation of hormonal circadian rhythms. 
In affective disorders, circadian rhythms may become desynchronized. The circadian rhythms of cortisol 
and estradiol may play a role in affective disorders. The purpose of this study was to explore the 
temporal relationship between the rhythms of cortisol and estradiol and its relationship to affect. It was 
hypothesized that a cortisol-estradiol phase difference (PD) exists that correlates with optimal affect. 
A small scale, comparative, correlational design was used to test the hypothesis. Twenty-three women 
were recruited from an urban university. Salivary samples were collected over a twenty-four-hour period 
and fitted to a cosinor model. Subjective measures of affect were collected. Relationships between 
the cortisol-estradiol PD and affect were evaluated using a second-degree polynomial equation. Results 
demonstrated a significant correlation in affect measures (p < 0.05). An optimal PD was identified for 
affect to be 3.6 hours. The phase relationship between cortisol and estradiol may play a role in the 
development of alterations in affective disorders.
Keywords: circadian; cortisol; estradiol; phase difference; affect
Background
Affective disorders impact the health of women 
world-wide, with a lifetime prevalence in women of over 
12 per cent [1]. Affect is the emotional process experi-
enced by individuals representing their psychological 
mood dispositions. Affect itself is the subjective and 
objective experience of emotions. Affect is closely associ-
ated with mood disorders including depression and anxi-
ety. Depression can be characterized by low positive affect 
and high negative affect. Women have higher rates of 
depression than men, which is unrelated to response and 
recall biases but may be related to sex hormones, genes, 
or gendered social roles [2]. Affective disorders have been 
correlated with reproductive cycle factors, such as the use 
of oral contraceptives, the luteal phase of the menstrual 
cycle, postpartum, and menopause [3]. Research suggests 
that in affective disorders, circadian rhythms may become 
desynchronized [4, 5].
Proper functioning of the human circadian system 
relies on synchronicity between the master clock, the 
suprachiasmic nuclei (SCN), and peripheral oscillators. It 
has been demonstrated in animal and in-vitro studies that 
peripheral clocks can maintain their rhythm independ-
ent of the SCN control [6]. This independence can alter 
the organization of the body’s circadian rhythms. This 
happens when peripheral oscillators become desynchro-
nized from the SCN. Effects of desychrony among internal 
circadian rhythms may contribute to the development 
of adverse health states. Studies support a relationship 
between circadian rhythm desynchrony and diseases. 
Cancer [7], metabolic disorders [8], immune dysfunction, 
inflammatory and stress responses [9] have been corre-
lated with desynchronized rhythms.
The purpose of this study was to investigate the relation-
ship between the synchrony of estradiol and cortisol, two 
hormonal rhythms, and affect in premenstrual white women.
Under natural environmental conditions, circadian 
rhythms are maintained to a 24-hour period by strong and 
weak entrainers [10, 11]. The most potent environmental 
entrainer is believed to be light. Animal model studies 
have revealed that peripheral circadian rhythms can be 
desynchronized by many mechanisms including the tim-
ing of feedings [12], activity and sleep [9], stress [13], body 
temperature and cortisol [14]. Areas where desynchrony 
has been shown to occur include tissue protein produc-
tion in the hypothalamus [15], liver [8], and the hypo-
thamic-pituitary-adrenal axis [14], inter alia. Non-photic 
entrainers include exercise, meals, social activity, and 
exogenous melatonin or serotonergic activation [16, 17].
Hogenesh et al [18] suggest that phase desynchrony 
may be related to different phase response curves for indi-
vidual tissues in response to a signal or a set of different 
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signals. Feedback loops of intracellular transcriptional-
translational gene expression regulate rhythmic protein 
production. Mutation in genes may result in phase length-
ening, shortening, and arrythmicity. The effects of the SCN 
are mediated indirectly by transcription factors allowing 
for peripheral oscillators to oscillate with different phases. 
[19] Phase setting of circadian rhythms appears to be a 
complex activity that can be influenced by many mecha-
nisms through numerous pathways. One method of deter-
mining synchrony of rhythms is by measuring the phase 
difference (PD) between two or more rhythms.
The PD is a measure of the temporal relationship 
between two rhythms. An optimal PD represents the tem-
poral relationship that may result in proper functioning in 
the human system. A suboptimal PD is one that is greater 
or smaller than the optimal PD and may be associated 
with less than optimal functioning. A suboptimal PD may 
reflect a desynchrony of rhythms.
Cortisol
Phase relationships have been studied for cortisol. Cortisol 
is a hormone that is expressed in the body in a circadian 
rhythm. In 90 per cent of healthy adults, cortisol peaks 
within 45 minutes of awakening, declines throughout the 
day and begins to rise during the night hours [20].
The peak of the cortisol rhythm may differ between 
healthy individuals and ill individuals. Studies of the cor-
tisol circadian rhythm in relationship to other physiolog-
ical processes have been conducted. Findings from these 
studies suggest that PDs exist between health and illness. 
Studies suggest that in Seasonal Affective Disorder (SAD), 
a disorder of mood, the mean cortisol rhythm itself is 
delayed. Avery and colleagues [21] found a phase differ-
ence between cortisol and thyroid stimulating hormone 
(TSH) in participants with SAD and controls. The corti-
sol minimum (0011 for SAD participants and 1003 for 
controls; p < 0.05) was delayed two hours in participants 
with SAD. While cortisol demonstrated a phase differ-
ence between the groups, the TSH phase position was 
not different between SAD participants and controls. 
Individual PDs were not reported but a two-hour cortisol 
phase delay in SAD participants might suggest that the 
cortisol-TSH PD between depressed and control partici-
pants differs.
The relationship changes between cortisol and prolactin 
have also been demonstrated. Koenigsberg and colleagues 
[22] compared 22 participants with major depression and 
20 healthy controls. In addition to cortisol, the authors 
analyzed growth hormone and prolactin rhythms but 
failed to compare the individual PD between rhythms. A 
phase advance in the acrophase of cortisol rhythm of one 
hour (p = 0.00002) was found. There were no differences 
in acrophase in prolactin or growth hormone, allowing 
for the possibility of a phase angle difference between 
cortisol and prolactin and growth hormone. Results were 
significant despite a diagnostically heterogeneous par-
ticipant group that included 69 per cent of the sample 
with endogenous depression, 25 per cent with psychotic 
depression, 38 per cent with agitated depression and 25 
per cent with retarded depression.
In other studies, the changes in the phase of the sample 
mean of cortisol does not vary in illness states. In these 
studies, other rhythms such as immune factors, growth 
hormone and prolactin are advanced or delayed relative 
to mood. Authors of these studies fail to analyze the indi-
vidual rhythm relationships, but mean differences may 
suggest the possibility of individual PDs in health and ill-
ness. Alesci and colleagues [23] studied the relationship 
between cortisol and plasma IL-6 levels. The mean phase 
position of both cortisol and IL-6 in depressed and non-
depressed participants were reported. PD differences were 
found in IL-6 but not cortisol.
Studies have been conducted to explore the timing of 
endogenous rhythms and sleep quality parameters, such 
as sleep onset. In an early study, the PD between the corti-
sol and the sleep rhythm was reported [24]. Depressed par-
ticipants demonstrated a smaller PD (p = 0.017) between 
cortisol nadir and sleep onset (188 minutes) compared 
with controls (239 minutes).
Estradiol
Estradiol demonstrates a circadian rhythm. The diurnal 
cycle of estradiol exhibits an early morning peak and 
two, three or four ultradian harmonics throughout the 
24-hour period [25]. During the menstrual phase, the 
peak in estradiol occurs later in the morning. The normal 
character of the estradiol rhythm is relatively unaffected 
by the menstrual cycle, except for the acrophase during 
the menstrual phase.
Studies involving the circadian rhythm of estradiol 
alone are few. Two studies have compared estradiol and 
cortisol circadian rhythms. Taleb, Krause and Goretzlehner 
[26] investigated cortisol and estradiol rhythms in women 
with preterm labor. They found that the cortisol rhythm 
was phase delayed in preterm labor compared to term 
labor. The estradiol rhythm did not differ in phase posi-
tion between preterm labor and term labor. The phase 
shift of cortisol in the absence of a similar phase shift in 
estradiol suggests a possible misalignment between the 
rhythms.
In a study by Bao and colleagues [27] circadian cortisol 
and estradiol rhythms in 27 women, 12 with a diagnosis of 
major depression were compared. As expected, both cor-
tisol and estradiol demonstrated clear diurnal rhythms. 
While in the control group the acrophases of cortisol 
and estradiol correlated, the acrophases in the depressed 
group demonstrated no correlation the late luteal phase. 
This may suggest that a coupling of cortisol and estra-
diol is present in healthy participants but not depressed 
women. A decoupling of the cortisol and estradiol phases 
may suggest a phase misalignment in depressed women 
but not healthy controls.
Through the findings of multiple studies, evidence 
has accumulated regarding the changing environmen-
tal milieu of reproductive hormones. The various phases 
of the menstrual cycle influence the actions of circadian 
rhythms. Premenstrual syndrome and premenstrual dys-
phoric disorder are characterized by changes in positive 
and negative affect, occurring predominantly during the 
luteal phase of the menstrual cycle [28, 29, 30, 31]. In other 
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studies conducted of the menstrual cycle, it has been sug-
gested that cortisol secretion varies over the cycle [32, 33].
Research in PDs has been limited to the relationship 
between exogenous rhythms such as timing and inten-
sity of light, temperature, humidity, sleep/wake, sound 
and a single endogenous rhythm [34]. Few researchers 
have investigated the PDs among multiple endogenous 
rhythms. Specifically, limited studies have been conducted 
to determine optimal PDs between cortisol and estradiol 
in relation to affect. Therefore, the purpose of the current 
study was to investigate the relationship between the syn-
chrony of estradiol and cortisol, two hormonal rhythms, 
and affect in premenstrual white women.
Methods
Design
A descriptive, comparative, correlational study design was 
used to explore the phase relationships between the bio-
logical rhythms of cortisol and estradiol and the correla-
tion of this relationship with affect.
Sample
Twenty-four women with normal menstrual cycles were 
recruited for this study. Most of the participants (n = 22) were 
from a population of urban university students. Two addi-
tional participants were community dwelling ambulatory 
women who resided in urban and rural areas of  southeast 
Michigan. Participants were recruited through invitation by 
the researcher at graduate and undergraduate classes at the 
university. It was emphasized that the  participation would 
not in any way affect course grades. Additional recruitment 
from the community was needed, as adequate sample size 
was not obtained through university recruitment. This was 
accomplished through flyers posted in public locations and 
direct approach by the investigator. Individual participants 
were informed of the study design, procedures, participant 
responsibilities and compensation. Written consent was 
obtained from all participants.
Inclusion criteria. Eligible participants had the following 
characteristics: a premenopausal female between 25 and 35 
years of age; regular menstrual cycles between 27–32 days; 
White; able to read and speak English; nonsmoker, or will-
ing to refrain from smoking during data collection; and 
major sleep period that occurred during the night.
Exclusion criteria. Exclusion criteria included: preg-
nancy or lactation within the past three months; prescrip-
tion drug use including oral contraceptives within the last 
three months; steroid use; illicit drug use; pre-existing 
diagnosis of any psychiatric disorder; pre-existing diag-
nosis of an endocrine disorder; pre-existing diagnosis 
of sleep apnea or periodontal disease; history of oopho-
rectomy; transmeridian travel across three or more time 
zones in the past month; shift work in the past three 
months; and occurrence of unusually high stress events 
such as divorce, death in the family, loss of job.
Setting
Data collection took place in the participant’s home or 
ordinary sphere of activity. The researcher initially met 
with the participant at a location convenient for the par-
ticipant, to explain the study and obtain signed informed 
consent.
Major Study Variables
The major variables of interest in this study were: salivary 
free cortisol circadian rhythm, salivary free estradiol circa-
dian rhythm, and affect. Significant bio-markers of endo-
crine function included cortisol and estradiol.
Salivary cortisol. Cortisol reflects the functioning of 
the hypothalmic-pituitary-axis (HPA) and salivary free cor-
tisol is equivalent to unbound cortisol in the body. Salivary 
cortisol was measured using Salimetrics’ expanded range, 
high sensitivity, salivary cortisol enzyme immunoassay kit 
(catalog number 1-3002/1-3012). This assay was designed 
to capture the lower levels of cortisol found in saliva when 
compared to serum. Intra-assay coefficients of variation 
range from 3.35per cent to 3.65 per cent. Inter-assay 
coefficients of variation range from 3.75 per cent to 6.41 
per cent. Linearity of dilution tests yield recovery results 
from 80.1 per cent to 97.9 per cent. Sensitivity has been 
reported to be < 0.003 mg/dL [35].
Salivary estradiol. Salivary free estradiol is the bio-
logically active form of estrogen in women of reproduc-
tive age. Estradiol has been shown to demonstrate both 
circadian and ultradian rhythms. Salivary estradiol was 
measured using Salimetrics’ high sensitivity salivary estra-
diol enzyme immunoassay kit (catalog number 1-3702/1-
3712). The intra-assay precision is determined for high, 
middle and low samples. Coefficients of variation are 7.0 
per cent, 6.3 per cent and 8.1 per cent, respectively. Inter-
assay precision has been reported for high and low sam-
ples with the coefficients of variation of 6.0 per cent and 
8.9 per cent, respectively [36].
Affect. Affect was measured on a bi-dimensional scale 
that includes positive and negative affect. Positive affect 
(PA) represents the degree to which an individual pleasur-
ably engages with the environment, while negative affect 
(NA) represents subjective distress [37]. PA is the degree 
to which an individual feels alert and excited. NA is the 
degree to which individual feels sad and lethargic.
Positive and negative affect were measured as inde-
pendent subscales using the Positive and Negative Affect 
Schedule (PANAS). The PANAS consists of 20 mood-based 
adjectives (10 to measure positive affect and 10 to meas-
ure negative affect) that the participant rates on a five-
point Likert scale. Affect is measured by the participant’s 
subjective experience response to each of the adjectives. 
Participants are asked to rate the extent to which the 
adjectives apply to them, using subjective estimates of 
their being (a) not a bit, (b) a little, (c) moderately, (d) quite 
a bit, or (e) extremely descriptive of them. The PANAS is 
scored by summing the responses related to PA and sum-
ming the responses related to NA. Adjectives reflective of 
PA include “active”, “attentive”, and “excited”. NA adjectives 
include “hostile”, “afraid” and “irritable”. Higher scores on 
the positive affect and lower scores on the negative affect 
subscales are considered indicative of higher levels of 
positive affect. The PANAS has been used extensively in 
clinical and nonclinical populations to assess affect under 
varying temporal instructions ranging from “today” to “in 
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general” [38, 39]. Internal consistency has been reported 
as high, with Cronbach alphas of .88 for the PA scale, and 
.85 for the NA scale [40].
This study also measured affect using the Profile of 
Moods (POMS) subscales Tension-Anxiety and Depression-
Dejection, and the POMS total score. The Tension-Anxiety 
subscale includes nine items measuring musculoskel-
etal tension and psychomotor agitation. The Depression-
Dejection subscale comprises 15 items measuring personal 
inadequacy, hopelessness, sadness, isolation and guilt. A 
global estimate of mood is given by the summation of the 
six subscales where the Vigor-Activity subscale is weighted 
negatively. Internal consistency for all subscales has been 
reported at .90 and above. Test-retest reliability ranges 
from .65 for Vigor to .74 for depression [41].
Data Collection Procedure
This study was approved by Wayne State University Insti-
tutional Review Board, protocol number 0911007749. 
Potential participants were approached by the principal 
investigator individually and in classroom settings at a 
Midwest urban university. After consent was obtained, 
the luteal phase of their menstrual cycle was determined 
from their previous menses. Collection of samples began 
between day 25 and 28 of the menstrual cycle. On the 
day of collection, each participant completed the demo-
graphic questionnaire, the PANAS, and the POMS. These 
were collected once on the first day of collection. As 
affect can vary over the day by as much as 10 points on 
a 100 point scale [42], with the nadir correlated with 
the body temperature nadir [43], the POMS and PANAS 
were administered in the early afternoon. Participants 
then received instruction in keeping a diary and the sali-
vary sampling protocol. The diary consisted of columns 
with the following headings: awake time, first collection 
time, any food eaten 60 minutes prior, second collection 
time, any food eaten 60 minutes prior. The column head-
ings repeated for a total of thirteen collection times. In 
addition, the diary asked the participant to record time 
of sleep, caffeine intake, and alcohol intake, for each 
collection time.
The sampling protocol for cortisol and estradiol was 
as follows. At every collection, the participant was asked 
to refrain from brushing or flossing the teeth until after 
the second collection of the day. Participants were not to 
eat within the hour before collection. Immediately prior 
to collection the participant rinsed her mouth with cool 
water. After a five-minute wait, the participant expecto-
rated through the straw provided into the sampling con-
tainer provided.
On the collection day, the participant was instructed 
to perform the sampling protocol at time of awakening, 
30 minutes later, and then every two hours around the 
clock for the remainder of the day, for a total of 13 sam-
ples. Collection materials were kept at the bedside dur-
ing the night and the participant was instructed to collect 
the sample in darkness while remaining in bed. Samples 
were kept on ice or refrigerated until retrieved by the 
researcher. Participants recorded collection times and any 
deviations from protocol in a diary.
Salivary Cortisol and Estradiol Collection. Salivary 
sampling employed a passive drool technique in which 
approximately 1.8 mL of saliva was collected by drooling 
down a straw into a collection vial according to manu-
facture recommended protocol. After retrieval from the 
participants, samples were frozen to 0 degrees Fahrenheit 
until analysis.
Assays were run in duplicate on 310 salivary sam-
ples using Salimetrics High Sensitivity Salivary Cortisol 
Enzyme Immunoassay Kits [35]. and Salimetrics High 
Sensitivity Salivary Estradiol Enzyme Immunoassay Kits 
[36]. Salivary cortisol and estradiol levels were determined 
by calculating the mean of the duplicate assay results. 
The quantitative measurement of cortisol and estradiol 
was determined by using an enzyme-linked immunoab-
sorbent technique (ELISA) according to manufacturer’s 
instructions [35, 36]. The intra-assay precision for the cor-
tisol assays was reported as 0.999 (SD = 0.033) μg/dL for 
high values and 0.097 (SD = 0.004) μg/dL for low values. 
The coefficients of variation were 3.35 and 3.65, respec-
tively. The lower limit of sensitivity for cortisol was 0.003 
μg/dL. The cortisol inter-assay precision was determined 
to be 1.020 (SD = 0.038) μg/dL for high values and 0.101 
(SD = 0.006) μg/dL. Coefficient of variation was 3.75 and 
6.41, respectively [35].
The intra-assay precision for the estradiol assay kits 
were reported as 20.26 (SD = 1.42) pg/ml for high val-
ues, 7.24 (SD = 0.45) pg/ml for mid-range values and 3.81 
(SD = 0.31) pg/ml for low values. Coefficients of variation 
were 7.0 per cent for high, 6.3 per cent for mid and 8.1 
percent for low values. Inter-assay precision was 24.62 
(SD = 1.47) pg/ml for high values and 4.76 (SD = 0.42) 
pg/ml for low values. Coefficients of variation were 6.0 
per cent for high values and 8.9 per cent for low values. 
The lower limit of sensitivity for estradiol is 1.0 pg/ml [36].
Data Analysis
All statistical analyses were completed using the Statisti-
cal Package for the Social Sciences (SPSS) version 19.0 for 
PC [44] and GraphPad Prism 5.0 for MacOS [45]. Descrip-
tive statistics, including mean, mode, standard deviation, 
range and skewness were used to describe the characteris-
tics of the sample and study variables. SPSS [44] was used 
to compute the descriptive statistics.
Results
Variables were examined to meet the assumptions of 
linear and nonlinear regression and correlation analy-
sis. Nonlinear regression was performed using GraphPad 
Prism 5.0 [45]. GraphPad Prism employs the Marquardt 
method of performing nonlinear regression. Automatic 
outlier elimination was performed using a Q value of 1 
per cent. Curve fitting was tested by visual examination of 
the raw data (see Figure 1) and curve fitting using Graph-
Pad Prism 5.0d constrained nonlinear regression analysis. 
The model selected was a multiple cosinor curve Y = M + 
A*cos(X-phaseshift) + B*cos(C*(X-d)), where M is the mean 
of the circadian rhythm and A is the circadian rhythm 
amplitude. B is the amplitude of the ultradian rhythm and 
C is the harmonic, where the second harmonic is equal to 
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eight hours, the third harmonic is six hours and the fourth 
harmonic is four hours. Finally, d is the phase position of 
the ultradian component.
Curves of two, three and four harmonics were compared 
using Akaike’s Informative Criterion (AIC) and the curve 
harmonic and the best fit was chosen. Independence of 
the variables of amplitude, mesor and phase was deter-
mined using descriptive and Pearson product-moment 
correlation statistics. The PD between cortisol and estra-
diol was determined by subtracting the estradiol acro-
phase from the cortisol acrophase. For values greater than 
12 hours, 24 was subtracted from the value, and for values 
less than –12 hours, 24 was added to the value to account 
for the circular nature of clock time. The cortisol-estradiol 
PD was regressed against the health indicators of affect 
using the quadratic equation Y = B0 +B1*X +B2*X^2. The 
quadratic model was compared to a straight line using the 
Extra Sum of Squares Fit Test. A p-value of 0.05 or less was 
used to determine significance. For models that fit a quad-
ratic equation significantly better than a straight line, the 
cortisol-estradiol PDs were examined for equivalency.
Initially, 24 participants were recruited for the study. 
One participant was subsequently removed from the 
analysis due to the inability to determine an estradiol 
acrophase. The final sample consisted of 21 (91.3 per cent) 
participants from the college of nursing and two (8.7 per 
cent) from the community. Sample characteristics are pre-
sented in Table 1. The mean age of the sample was 28.7 
(SD = 5.8) years with an inclusive range of 21 to 39 years. 
The mean BMI was 24.7 (SD = 4.5) Kg/m2 with a range 
from 18.0 to 41.6 Kg/m2.
The mean scores on the two PANAS subscales and the 
POMS can be found in Table 1. Cronbach’s alpha in this 
study for the PANAS positive affect subscale was .92. 
Cronbach’s alpha for the PANAS negative affect subscale 
was .86. On the POMS scale, Cronbach’s alpha for the 
total scale was .81, with a Cronbach’s alpha of .90 for the 
Depression-Dejection subscale, and .79 for the Tension-
Anxiety subscale.
Cortisol was measured using the Salimetrics High 
Sensitivity Cortisol Enzyme Immunoassay. The Salimetrics 
High Sensitivity Salivary Cortisol Enzyme Immunoassay 
has a sensitivity to detect 0.003 μg/dL, with serum cor-
relation of 0.9. The intra-assay coefficients of variation 
for this study were 6.7 for cortisol and the inter-assay 
coefficients of variation were 11.9. Estradiol was meas-
ured using the Salimetrics High Sensitivity 17β-Estradiol 
Enzyme Immunoassay. The Salimetrics High Sensitivity 
Salivary 17β-Estradiol Enzyme Immunoassay has a sensi-
tivity of 0.01 pg/mL, with serum correlation of 0.80. The 
intra-assay coefficients of variation for this study were 
9.32 and the inter-assay coefficients of variation were 13.3. 
For the estradiol samples, the pH indicator in the assay 
diluent indicated a possible saliva pH outside of accept-
able parameters. A pH test was performed on a random 
15 per cent of the saliva samples. None of the pH values 
were below the acceptable value of 5. Six (19.3 per cent) 
random samples were slightly higher than the acceptable 
upper limit of nine with values ranging from 9.03 to 9.64. 
Elevated pH may artificially lower the estradiol values.
The mean cortisol-estradiol PD of the full sample is 
reported in Table 1. The cortisol-estradiol PDs and the 
health measures were then modeled to the equation 
Y = B0 +B1*X +B2*X^2. Goodness of fit was determined 
using the R2 values, D’Agnostino’s normality of residuals, 
run tests and visual inspection of the data points (Table 2).
Figure 1: Cortisol and Estradiol Curve Fit.
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Table 2: Goodness of Fit for Cortisol and Estradiol Curve (N = 23).
Cortisol Curve Estradiol Curve
Participant R2 Normality 
of residuals
p-Value Run Test 
p-value
R2 Normality 
of Residuals
p-value Run Test 
p-Value
1 0.47 18.14 0.000* 0.296 0.46 0.042 0.980 0.966
2 0.55 .794 0.672 0.296 0.40 1.333 0.513 0.999
3 0.95 1.067 0.587 0.976 0.72 0.105 0.949 0.881
4 0.32 17.75 0.000* 0.576 0.68 0.340 0.843 0.043*
5 0.46 2.973 0.226 0.911 0.51 1.359 0.507 0.733
6 0.52 7.302 0.026* 0.576 0.55 0.349 0.839 0.966
7 0.88 1.612 0.447 0.533 0.56 1.987 0.371 0.954
9 0.77 7.756 0.021 0.606 0.74 0.889 0.641 0.966
10 0.63 0.229 0.892 0.347 0.54 6.045 0.049* 0.929
11 0.73 1.940 0.379 0.879 0.57 5.175 0.075 0.347
Table 1: Descriptive Statistics.
Total Sample (n = 23)
Characteristic Mean (SD) Range Number (%)
Age 28.7(5.8) 21–39
BMI 24.7(4.5) 18.0–41.6
Marital Status
Married 6(26.1)
Single 6(69.6)
Divorced/Separated 1(4.3)
No. Children1
None 15(65.2)
1 to 5 years 3(13.0)
6 to 12 years 4(17.4)
Education
High School 5(21.7)
Bachelor’s Degree 16(69.6)
Master’s Degree 2(8.7)
Daily Caffeine (cups) 1.3(1.1) 0–4
POMS
Total Scale Score 15.4(24.1) –24– + 86.8
Depression-Dejection Subscale Score 5.2(6.9) 0–25
Tension-Anxiety Subscale Score 6.3(4.2) 0–16
Fatigue-Inertia Subscale Score 7.3(5.4) 0–23
Vigor-Activity Subscale Score 14.6 (5.5) 3–25
PANAS
Positive Affect Subscale 33.6(8.3) 13–46
Negative Affect Subscale Score 17.3(5.7) 10–30
SSQ Scale Score 4.5(.97) 1.71–5.93
PSQI Scale Score 3.5(1.7) 1–8
Energy VAS-Energy Scale Score 72.7(14.8) 45.3–113.3
Cortisol Acrophase (hours) 9.2(3.4) 2.06–15.01
Estradiol Acrophase (hours) 9.9(7.4) .19–22.19
Cortisol-Estradiol PAD (hours) 2.7(5.0) –7.9–11.92
1 n = 22 for this variable.
(contd.)
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Affect. The curves generated from the cortisol-estradiol 
PD and affect measures demonstrated data points that vis-
ually appear close to the curve in all scales (see Figure 2). 
Goodness of fit results can be seen in Table 3. For the 
sample, correlations of the cortisol-estradiol PD with the 
affect scales ranged from 0.28 for Positive Affect to 0.36 
for the Depression-Dejection subscales. All the affect 
scales fit the quadratic model significantly better than a 
Figure 2: Curve Fit to Y = B0 + B1*X + B2*X^2 for Affect Measures and Cortisol-Estradiol PD.
Cortisol Curve Estradiol Curve
Participant R2 Normality 
of residuals
p-Value Run Test 
p-value
R2 Normality 
of Residuals
p-value Run Test 
p-Value
12 0.56 1.182 0.554 0.999 0.66 1.687 0.430 0.966
13 0.75 3.372 0.185 0.879 0.45 3.575 0.137 0.879
14 0.78 1.431 0.489 0.347 0.35 2.246 0.325 0.966
15 0.54 4.246 0.120 0.878 0.67 1.577 0.454 0.793
16 0.73 0.601 0.740 0.576 0.49 1.444 0.486 0.347
17 0.55 1.182 0.554 0.879 0.38 0.858 0.651 0.966
18 0.62 0.015 0.993 0.500 0.50 0.480 0.787 0.733
19 0.75 1.438 0.487 0.500 0.37 1.287 0.526 0.966
20 0.57 3.876 0.144 0.879 0.49 3.822 0.148 0.999
21 0.90 0.999 0.607 0.879 0.52 0.356 0.837 0.500
22 0.60 11.150 0.004* 0.652 0.88 5.200 0.074 0.47
23 0.69 11.850 0.003* 0.348 0.29 0.258 0.879 0.793
24 0.83 2.186 0.335 0.296 0.39 0.480 0.043* 0.296
*One-tailed significance level p < 0.05.
Butler: Cortisol-Estradiol Phange AngleArt. 3, page 8 of 12  
straight line at p < 0.05. One subscale violated the normal-
ity of residuals assumption suggesting possible systematic 
error. Significance was found for D’Agnostino’s normal-
ity of residuals test for Positive Affect (K2 = 7.3, p = 0.02). 
All run tests were nonsignificant in the affect measures 
(Table 4).
Discussion
This study employed two questionnaires and two biologi-
cal measures. Two subscales of the POMS questionnaire, 
and two subscales of the PANAS were the subjective meas-
ures used for this study.
Affect
The two subscales of the Positive and Negative Affect 
Scales (PANAS) were used to measure affect in this study. 
Mean scores for this sample were 33.6 for PA and 17.3 for 
NA. Studies with university students found similar scores 
that ranged from 29 to 36 for PA and 15 to 22 for NA 
[40]. The Salimetrics High Sensitivity Salivary Cortisol 
Enzyme Immunoassay had acceptable sensitivity (0.003). 
The intra-assay and the inter-assay coefficients of varia-
tion were reliable at 6.7 and 11.9, respectively. Intra-assay 
coefficients of variation less than 10 and interassay coef-
ficients of variation less than 15 are considered acceptable 
[35]. Cortisol intra and inter assay coefficient of variation 
were similar in other studies [46, 47].
The Salimetrics High Sensitivity Salivary Estradiol 
Enzyme Immunoassay intra-assay and inter-assay coeffi-
cients of variation were reliable at 9.3 and 13.3, respec-
tively. These coefficients of variation are similar to those 
found in other published studies [27, 48].
In all participants, the cortisol and estradiol data con-
verged on a cosinor model. Cortisol data demonstrated 
greater curve fit with less sum of squares differences 
(R-values) than estradiol. Correlation coefficients for cor-
tisol ranged from 0.32 to 0.95 with only two data sets cor-
relating at less than 0.50. Estradiol correlation coefficients 
ranged from 0.29 to 0.88 with ten data sets correlating at 
less than 0.50. The multioscillator cosinor model has been 
used to model circadian rhythm in several studies [22, 25]. 
The cortisol data fit the curve model better than the estra-
diol data suggesting the possibility that the circadian and 
ultradian profile of estradiol expression may follow a dif-
ferent model from that of cortisol.
Five out of 23 data sets violated normality of residuals 
assumptions in the cortisol curve fit and two violated the 
normality of residuals assumptions in the estradiol curve 
fit at significance levels less than 0.05. In four of the five 
cortisol curves and one of the two estradiol curves the lack 
of normal distribution may be accounted for by an outlier. 
In each cortisol case the outlier may indicate the morning 
cortisol awakening response. In the estradiol curve, the 
outlier is the highest value and may represent the acro-
phase or may be due to measurement error. Violation of 
the normality assumptions suggests a systematic explana-
tion for deviation from the chosen model. In the cortisol 
curves, the model may not adequately capture the corti-
sol awakening response. Cortisol has consistently demon-
strated a robust circadian and ultradian rhythm [49, 50]. 
Few studies have examined the circadian rhythm of sali-
vary estradiol. Bao and colleagues [25] sampled 15 women 
every two hours for 24 hours at four times during the men-
strual cycle, fitting the estradiol data to a cosinor rhythm. 
The authors found the data to fit a peaked diurnal rhythm 
with ultradian harmonics that demonstrated a mean acro-
phase in the early morning. In this current study, most 
participants’ estradiol curves fit the model without violat-
ing assumptions, and the correlations were lower than for 
cortisol. Findings of this study are consistent with Bao and 
coworkers [25].
The optimal PD mean value was 3.60 (SD = 0.26) hours, 
determined by the mean of the optimal PD of the five 
Table 3: Goodness of Fit for Cortisol-Estradiol PD and Affect Measures for Sample (N = 23).
Goodness of Fit Straight Line
R2(DF) Normality
of Residuals (p)
Run Test p F(DFn, DFd) p
Affect
POMS Total Score .34(20)1 1.4(0.50) 0.97 5.8(1,20) 0.022
POMS Depression-Dejection Score .36(20) 0.81(0.66) 0.96 6.5(1,20) 0.022
POMS Tension-Anxiety Score .30(20)1 5.9(0.05) 0.90 4.4(1,20) 0.0482
Positive Affect Score .28(20)1 7.3(0.02)2 0.54 4.5(1,20) 0.0472
Negative Affect Score .30(20)1 1.6(0.44) 0.51 6.21(1,20) 0.022
Notes: Model: Y = B0 + B1*X + B2*X^2. POMS = Profile of Moods;
1 Correlation greater than 0.25;
2 Significant at p < .05.
3 Trend to significance at p between 0.05 and 1.00.
Table 4: Optimal Cortisol-Estradiol PD Based on 
Curve Fit (N = 23).
Affect
POMS Total Score 3.23
POMS Depression-Dejection Score 3.78
POMS Tension-Anxiety Score 3.90
Positive Affect Score 3.50
Negative Affect Score 3.57
PD = Phase Difference; POMS = Profile of Moods State; PD in hours
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affect measures. All optimal PDs for the affect measures 
were between 3.23 and 3.90 hours. These findings support 
the those found in the literature. Several studies identified 
optimal PDs between hormones and the sleep parameters 
of wake, midsleep and dim-light melatonin onset (DLMO) 
in depression. Depression severity has shown a linear asso-
ciation with the DLMO-wake time and the DLMO-sleep 
time PDs in 18 depressed women. Depression severity 
demonstrated a linear relationship between temperature-
midsleep PD and the DLMO-temperature PD, however 
no group differences were noted [51]. PD between tem-
perature minimum and wake time in 43 SAD participants 
suggested a trend toward a three-hour PD associated with 
reduction in symptoms after light treatment that was 
not statistically significant [52]. Group differences in cor-
tisol-DLMO were found in six healthy and six depressed 
individuals, with approximately a two-hour greater PD 
in depressed participants [53]. In addition, a six-hour 
optimal PD was demonstrated between DLMO and mid-
sleep in winter depression [54]. Except for Buckley and 
Schatzberg [53], no studies have investigated an optimal 
PD between two endogenous hormones.
Strength
This study was the first known to investigate the PD 
between cortisol and estradiol and the relationship 
between the cortisol-estradiol PD and affect. This study 
has several strengths. In this, cortisol and estradiol were 
measured every two hours across an entire 24-hour 
period. The cortisol awakening response was captured 
by an additional saliva collection 30 minutes follow-
ing wake time for a total of 13 saliva samples per par-
ticipant. Multiple sampling across the 24-hour period 
allows for greater confidence in modeling the circadian 
and ultradian rhythms. Another strength was the use 
of multiple measures for affect. To reduce confound-
ing variables the sample was homogenous for race and 
occupation. Saliva samples were obtained at the same 
time in the luteal phase of the menstrual cycle for all 
participants, avoiding differences in circadian rhythm 
characteristics due to phase of the menstrual cycle. This 
study was further strengthened by the natural setting in 
which saliva was collected. A natural setting allows for 
hormone expression in the body that is more consist-
ent with the participant’s daily secretion patterns. This 
study provided insight into the relationships between 
circadian rhythms within the individual, as opposed to 
aggregate means.
Limitations
This study was limited by several factors. First, the rela-
tionships tested must be understood as associations, 
not causal relationships. Generalizability is limited by 
the homogeneity and small size of the sample. The con-
venience sample was selected primarily from a cohort of 
graduate and undergraduate nursing students at an urban 
university. Education level, student status and race were 
similar across the sample. The sample consisted of 23 
women; too small for adequate power to determine group 
differences. Non-significant findings may be a result of 
type II error and significant findings may possibly be spu-
rious due to the small sample size.
Another design limitation was the sampling method of 
every two hours over a single 24-hour period. It is opti-
mal to sample salivary hormone over several days and take 
the mean values to more accurately model the circadian 
rhythms. Numerous studies that employ salivary samples 
across the day have been limited to two to six samples. 
Study designs that use laboratory conditions and plasma 
sampling provide the opportunity to perform sampling at 
greater frequencies. The optimal number of salivary sam-
ples needed for both adequate curve fit and minimizing 
interruption to normal daily activities has not been ade-
quately studied. Sampling every two hours has been sug-
gested to be acceptable, however, a higher sampling rate 
may provide greater confidence in the rhythm parameters.
Subjective measures of affect, sleep quality and energy 
level, and self-report compliance threaten validity. 
Subjective measures have been found to inconsistently 
correlate with objective measures [53]. Sampling in a nat-
ural environment prohibits researcher oversight of partici-
pant compliance with study procedures. Abnormally high 
pH values in 19 per cent of the estradiol samples may rep-
resent an additional threat to assay validity from poten-
tially contaminated specimens.
Conclusions
In this study the circadian characteristics of two hormones 
in healthy women and their relationship to affect were 
investigated. This study endeavored to explain the mecha-
nisms by which affective disorders emerge from the inter-
play of various circadian rhythms. Understanding the PDs 
among rhythms in humans holds the potential to under-
stand the development of the symptoms that are common 
to many disease processes. This study contributes knowl-
edge by suggesting a possible phase relationship between 
cortisol and estradiol that is implicit in lower affect in 
healthy women. Lower affect may be a significant con-
tributory symptom in the development of depression and 
other affective disorders.
Based on the possible relationship between the cortisol-
estradiol PD and affect, phase shifting interventions can 
be developed and tested to determine their effects on 
depression, premenstrual syndrome, and premenstrual 
dysphoric disorder, inter alia. The emerging model may 
suggest phase responses between cortisol and estradiol 
may differ based on the specific entrainer. The possibility 
that cortisol may represent an arousal-dependent rhythm 
while estradiol may represent an arousal-independent 
rhythm is suggested. Arousal-independent phase shift-
ers include melatonin and g-Aminobutyric acid (GABA). 
Arousal-dependent non-photic phase shifters include 
serotonin [55]. Explicating a model for phase-setting in 
human health provides a method by which to explore 
additional, yet unknown, phase entrainers. Measuring 
the effects of entrainers on an optimal cortisol-estradiol 
PD can contribute to understanding the potential role of 
interventions in the alleviation of symptoms of illness. 
Potential entrainers may include such diverse phenom-
ena as music, visual art, and physical/temporal order 
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or disorder among many others. Much more research is 
needed to understand the effects of specific entrainers on 
affective disorders.
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